ABC-06 Trial – Information update Index Latest Topics Login Register Lost Password Forum Guidelines Discussion Forum › Discussion Forum › Clinical Trials and Treatments › ABC-06 Trial – Information update This topic contains 0 replies, has 1 voice, and was last updated by Helen_ammf 2 years, 6 months ago. Viewing 1 post (of 1 total) Author Posts September 30, 2016 at 7:24 pm #9559 Helen_ammfModerator ABC-06 is a 2nd line chemotherapy trial, suitable for those who have had already had the Gemcitabine/Cisplatin chemotherapy, or who now have metastatic disease. However, this is a randomized trial with two arms – Active Symptom Control with ‘OxMdG’ chemotherapy (Oxaliplatin, L-folinic acid & 5FU) – against – Active Symptom Control AMMF has been informed this week (26.09.16) that patients taking part in either arm of this trial may also participate in relevant Phase I trials, if eligible. So if the decision is made to go for ABC-06, but you are randomised to the Active Symptom Control arm you can be considered for any suitable Phase I trial straight away*. For those randomised to the chemotherapy arm, at least 28 days after their last chemotherapy treatment should be allowed before starting a Phase I trial. For more information about this, and contact details, see: https://ammf.org.uk/clinical-trials/ *This should always be done in consultation with the ABC-06 trial office. Author Posts Viewing 1 post (of 1 total) You must be logged in to reply to this topic.